Roche Licenses Rona Obesity Therapy in Deal Worth Up to $1.2 Billion

Roche struck a deal with China's Rona Therapeutics for worldwide rights to an experimental therapy for obesity and metabolic diseases, with payments of up to $1.16 billion.